What Is a Good Substitute for Trazodone for Sleep?

The best substitute for trazodone depends on why you’re switching and what kind of sleep trouble you have, but several well-studied alternatives exist across prescription, over-the-counter, and non-drug categories. Low-dose doxepin, orexin receptor antagonists like suvorexant and lemborexant, the melatonin receptor agonist ramelteon, the sedating antidepressant mirtazapine, and cognitive behavioral therapy for insomnia (CBT-I) all have meaningful evidence behind them. The right pick hinges on whether your main problem is falling asleep, staying asleep, or waking too early, and on whether you’re also managing depression, pain, or other conditions that trazodone was pulling double duty for.

Why People Look for Alternatives

Trazodone is one of the most commonly prescribed sleep aids in the United States, yet it has never been FDA-approved specifically for insomnia. Doctors prescribe it off-label at low doses, typically 25 to 100 mg, because its sedating side effects happen to help with sleep. That off-label status means the clinical trial data supporting its use for insomnia is thinner than what exists for drugs designed from the ground up as sleep aids. Many people do well on it for months or years, but common reasons to look for a replacement include next-day grogginess, dizziness, dry mouth, weight changes, or a nagging feeling that a medication actually approved for sleep might work better and carry fewer unknowns.

Another reason to switch is that trazodone can interact with other serotonin-affecting drugs, raising the theoretical risk of serotonin syndrome. If your prescriber adds an SSRI, an SNRI, or a triptan for migraines, they may want to pull trazodone out of the mix. And for some people, trazodone simply stops working over time, prompting a conversation about what to try next.

Low-Dose Doxepin

If you liked that trazodone is an antidepressant repurposed for sleep, low-dose doxepin is the closest FDA-approved cousin. Doxepin is a tricyclic antidepressant, but at very low doses (1, 3, or 6 mg) it works almost entirely by blocking histamine H1 receptors, the same receptors that antihistamines like diphenhydramine target. The difference is that doxepin binds those receptors with extremely high affinity, so it can be effective at doses far lower than what you’d need for antidepressant effects.¹

Clinical trials lasting up to three months found that low-dose doxepin improved sleep onset, sleep maintenance, and early-morning awakening without disrupting normal sleep architecture. There was no signal for tolerance, rebound insomnia, or next-day psychomotor impairment, and the most commonly reported side effects, drowsiness and headache, occurred at roughly the same rate as placebo.² That tolerability profile makes doxepin a particularly strong candidate if your main complaint with trazodone was morning hangover or grogginess. Its sweet spot is sleep maintenance insomnia, meaning you fall asleep fine but wake up repeatedly during the night or too early in the morning.

Orexin Receptor Antagonists

The newest class of FDA-approved sleep drugs, dual orexin receptor antagonists (sometimes abbreviated DORAs), works by a completely different mechanism than trazodone or any older sedative. Instead of sedating you, these drugs block orexin, a brain chemical that keeps you awake. The result is that your brain’s arousal drive is dialed down, letting the natural sleep process take over.³

Three orexin blockers are currently available: suvorexant (Belsomra), lemborexant (Dayvigo), and daridorexant (Quviviq). All three help with both falling asleep and staying asleep, which gives them an advantage if you have trouble with both halves of the night. A systematic review and network meta-analysis found no evidence that these drugs cause tolerance, withdrawal symptoms, or rebound insomnia when stopped, and they preserve normal sleep architecture rather than distorting it the way some older sedatives do.⁴

Orexin blockers also appear to carry substantially lower real-world abuse and misuse potential than trazodone. An analysis of adverse-event reporting data found that DORAs were associated with significantly fewer reported cases of abuse, misuse, and overdose compared with both trazodone and Z-drugs like zolpidem.⁵ The practical downside is cost. These are brand-name medications with no generic versions yet, so insurance coverage can be spotty and out-of-pocket prices are steep. If cost is a barrier, this class might be worth revisiting as patents expire.

Ramelteon for Sleep-Onset Problems

If your insomnia is mainly about lying in bed unable to fall asleep, ramelteon (Rozerem) targets that specific problem. It’s a prescription melatonin receptor agonist, meaning it mimics melatonin but binds more powerfully and selectively to the MT1 and MT2 receptors that regulate your sleep-wake cycle. The FDA approved it specifically for insomnia characterized by difficulty falling asleep, and clinical studies showed it reduced the time to fall asleep without any rebound insomnia or abuse potential.⁶

Unlike trazodone or benzodiazepines, ramelteon doesn’t impair motor coordination. An animal study testing motor performance found no impairment even at doses well above the therapeutic range, and it didn’t worsen the coordination problems caused by diazepam, either.⁷ That makes ramelteon a reasonable choice for anyone concerned about nighttime falls, including older adults. The trade-off is that it’s less helpful for staying asleep. If you wake at 3 a.m. and can’t get back down, ramelteon alone probably won’t solve that.

Mirtazapine as a Sedating Antidepressant Swap

For people who were taking trazodone both for sleep and for mild depression or anxiety, mirtazapine (Remeron) is a natural alternative to consider. It’s another antidepressant with strong sedating properties at low doses, and it works through a different receptor profile than trazodone, primarily blocking histamine and certain serotonin receptors. A long-term retrospective study comparing the two found that both drugs were effective for chronic insomnia in more than 85% of patients, with virtually no difference in the proportion who responded well. The lowest tested doses, 25 mg for trazodone and 7.5 mg for mirtazapine, were the most commonly effective, and neither drug showed problems with tolerance over sustained use.⁸

Mirtazapine does come with a well-known appetite-stimulating effect. Weight gain is among the most common complaints, so if that was already a concern with trazodone, mirtazapine may not be the ideal swap. On the other hand, if you’ve lost weight due to illness, anxiety, or another medication that suppresses appetite, the extra hunger could be a welcome side benefit. Mirtazapine’s efficacy held regardless of whether patients also had depression, which suggests it works for sleep through mechanisms that are somewhat independent of its antidepressant action.

Cognitive Behavioral Therapy for Insomnia

CBT-I is the treatment most sleep specialists recommend as a first-line approach, ahead of any medication. It’s a structured program, usually four to eight sessions, that retrains the habits and thought patterns that perpetuate insomnia. The core components include stimulus control (only going to bed when sleepy, using the bed only for sleep), sleep restriction (temporarily limiting time in bed to consolidate sleep), and cognitive restructuring (addressing the anxious thoughts that keep the brain buzzing at night).

A meta-analysis comparing digital CBT-I programs with medication therapy found that CBT-I produced larger reductions in insomnia severity at one, three, and six months, with the gap widening over time. By three months, the advantage of CBT-I over medication was in the moderate effect-size range.⁹ That finding is important because medications tend to work only while you’re taking them, whereas CBT-I teaches skills you keep using after the program ends. The benefits often persist for months to years after treatment.

The catch is access. Traditional in-person CBT-I with a trained therapist can be hard to find and expensive. App-based and online versions have become much more widely available and show similar benefits, but they require you to actually do the homework, which means tracking sleep, following sometimes counterintuitive instructions (like getting out of bed when you can’t sleep), and tolerating a period of increased tiredness while the technique takes hold. If you’re looking for an alternative to trazodone because you’d prefer to stop relying on nightly medication, CBT-I is the strongest evidence-backed path to that goal.

Over-the-Counter Antihistamines and Supplements

Many people’s first instinct when quitting a prescription sleep aid is to reach for something at the drugstore. Diphenhydramine (Benadryl, ZzzQuil) and doxylamine (Unisom SleepTabs) are sedating antihistamines available without a prescription, and they do cause drowsiness. But tolerance builds quickly, often within a few days of nightly use, which makes them poor long-term substitutes for trazodone. They also carry anticholinergic side effects like dry mouth, constipation, urinary retention, and next-day cognitive fog. These effects are especially concerning in older adults, where anticholinergic medications have been linked to increased confusion and fall risk.

Supplements are a softer alternative, and their popularity has grown enormously. A review of common dietary supplements for sleep found that melatonin, magnesium, zinc, L-theanine, and vitamin D all have plausible physiological mechanisms that could affect sleep, but the clinical trial evidence varies widely in quality and consistency.¹⁰ Melatonin has the most evidence behind it. It’s generally safe and works best when the issue is circadian timing, such as jet lag, shift work, or a delayed sleep phase where your body clock runs late. For garden-variety insomnia, melatonin’s effect is modest. It shaves a few minutes off the time to fall asleep but doesn’t reliably help with middle-of-the-night waking. Magnesium glycinate has some promising preliminary data for relaxation and sleep, but it’s far from proven. Neither melatonin nor magnesium is a one-to-one replacement for a prescription sedating agent.

Off-Label Options Worth Knowing About

Gabapentin is an anticonvulsant drug that has gained popularity as an off-label sleep aid, particularly in people whose insomnia coexists with chronic pain, restless legs, or neuropathy. It enhances slow-wave sleep, the deepest phase of sleep, and has been shown to improve sleep efficiency and reduce nighttime awakenings in people with both primary sleep disorders and medically related sleep disturbance.¹¹ If your insomnia is tangled up with pain that keeps waking you, gabapentin can address both issues simultaneously, which is a meaningful advantage over trazodone.

Quetiapine (Seroquel) is another medication sometimes prescribed off-label for sleep, especially in people with psychiatric conditions like bipolar disorder or treatment-resistant depression. It’s powerfully sedating at low doses. However, even at the low doses typically used for insomnia, metabolic side effects are real. One study found that patients gained an average of about five pounds and saw increases in their body mass index even on the modest doses prescribed for sleep.¹² Quetiapine is an atypical antipsychotic, not a sleep medication, and carrying those metabolic risks purely for insomnia without an underlying psychiatric indication is a trade-off most clinicians hesitate to endorse. It makes the most sense when there’s already a psychiatric reason to use it and the sleep benefit is a secondary gain.

Matching the Substitute to Your Insomnia Pattern

Not all insomnia is the same, and the substitutes line up differently depending on which part of your night is broken. Expert reviews on pharmacotherapy selection emphasize that the choice should be guided by the insomnia phenotype, whether your problem is at the beginning, middle, or end of the night, as well as your other health conditions.¹³

Trouble falling asleep: Ramelteon is specifically approved for this. Melatonin supplements can also help if the issue is circadian timing. Orexin blockers work here too but are broader-acting.
Waking up repeatedly: Low-dose doxepin is a strong choice. Orexin blockers also help with maintenance. Gabapentin may be especially useful if pain or restless legs are driving the awakenings.
Waking too early: Low-dose doxepin has data specifically supporting early-morning awakening. Mirtazapine’s long sedation duration may also help bridge those last hours of sleep.
Both onset and maintenance: Orexin blockers cover both ends of the night. CBT-I, while not a pill, addresses the full insomnia pattern over time.

If trazodone was also managing depression or anxiety, a straight sleep medication like doxepin or suvorexant won’t fill that gap. In that case, combining a dedicated sleep intervention (CBT-I or a targeted hypnotic) with an antidepressant that doesn’t cause insomnia as a side effect may be the better strategy. Your prescriber can help sort out which piece trazodone was covering.

What the Large-Scale Evidence Says

A large network meta-analysis published in The Lancet reviewed 154 randomized controlled trials covering 30 different insomnia interventions in adults, making it one of the most comprehensive comparisons available.¹⁴ The sheer size of the evidence base for some of these drugs, and the thinness of it for others, is itself informative. Trazodone, despite being widely used, has relatively little high-quality trial data compared with the FDA-approved options. That doesn’t mean it doesn’t work; clearly many people benefit from it. But it does mean that when you switch to a drug like lemborexant or low-dose doxepin, you’re often moving to a medication with stronger formal evidence behind it, not weaker.

Long-term data remains a weak spot for most insomnia medications. The Lancet review found only five trials examining long-term efficacy, covering just five different drugs. That means for any medication you switch to, the strongest confidence in its effects comes from the first few months. After that, you’re relying on clinical experience, which is abundant for some of these drugs but is not the same as randomized trial proof. CBT-I stands out here because its long-term follow-up data is genuinely strong, with benefits lasting well beyond the treatment period.

Older Adults and Fall Risk

If you’re over 65 or managing sleep for a parent or grandparent, the calculus around substitutes shifts. Older adults metabolize sedating drugs more slowly, amplifying next-day effects, and any medication that causes drowsiness, dizziness, or coordination problems raises fall risk. Benzodiazepines are especially problematic on this front. Ramelteon’s lack of motor-coordination impairment makes it one of the safer options in this age group.⁷ Low-dose doxepin is also used in older adults, partly because the very low doses needed for histamine-blocking mean less overall drug exposure. CBT-I has been studied extensively in older populations and works well, though adherence to sleep restriction can be harder when daytime napping has become a deeply ingrained habit.

Over-the-counter antihistamines like diphenhydramine deserve special caution in this group. Their anticholinergic properties can worsen cognitive function, contribute to delirium, and increase fall risk, all problems that tend to be more severe and more dangerous in older adults than in younger ones. Many geriatric prescribing guidelines now explicitly recommend against diphenhydramine for insomnia in people over 65.

How to Transition Safely

Trazodone is an antidepressant, and even at the low doses used for sleep, stopping it abruptly can sometimes cause discontinuation symptoms. These might include irritability, nausea, headache, dizziness, or a brief return of more intense insomnia. If you’ve been taking trazodone nightly for more than a few weeks, a gradual taper, reducing the dose over one to three weeks depending on how long you’ve been on it, is usually the safer approach. Your prescriber can guide the pace of the taper and time the introduction of the replacement so you’re not left with uncovered nights.

It’s also worth giving any new sleep medication a fair trial before concluding it doesn’t work. Ramelteon, for example, sometimes takes a week or two before the benefit is fully apparent. CBT-I typically requires four to six weeks before sleep starts consolidating. The temptation to switch again after two bad nights is understandable, but most insomnia treatments need more runway than that. Keeping a simple sleep diary during the transition, noting when you went to bed, roughly how long it took to fall asleep, how many times you woke, and when you got up, gives both you and your doctor useful information for deciding whether the new approach is actually working.